Synergic effect of grape seed extract with amphotericin B against disseminated candidiasis due to Candida albicans

Phytomedicine

Volumn 14, Issue 11, 2007, Pages 733-738

  Han, Yongmoon ^a  

^a Dongduk Women's University   (South Korea)

Author keywords

Amphotericin B; Candida albicans; Disseminated candidiasis; Grape seed extract; Susceptibility; Synergic effect

Indexed keywords

AMPHOTERICIN B; GRAPE SEED EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG POTENTIATION; FEMALE; FUNGUS GROWTH; GRAPE; GROWTH INHIBITION; INVASIVE CANDIDIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; YEAST CELL;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PLANT EXTRACTS; SEEDS; VITIS;

CANDIDA ALBICANS; FUNGI; MURINAE; MUS; VITACEAE;

EID: 35148821145     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.08.004     Document Type: Article

References (35)

1. Ahn J., Grun I.U., and Mustapha A. Antimicrobial and antioxidant activities of natural extracts in vitro and in ground beef. J. Food Prot. 67 (2004) 148-155
2. Ahn J., Grun I.U., and Mustapha A. Effects of plant extracts on microbial growth, color change, and lipid oxidation in cooked beef. Food Microbiol. 24 (2007) 7-14
3. Anttila V.J., Ruutus P., Bondestam S., Jansson S.E., Nordling S., et al. Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clin. Infect. Dis. 18 (1994) 979-981
4. Bodey G.P. The emergence of fungi as major hospital pathogens. J. Hosp. Infect. 11 Suppl. A (1988) 411-426
5. Donini M., Zenaro E., Tamassia N., and Dusi S. NADPH oxidase of human dendritic cells: role in Candida albicans killing and regulation by interferons, dectin-1 and CD206. Eur. J. Immunol. 37 (2007) 1194-1203
6. Du Y., Guo H., and Lou H. Grape seed polyphenols protect cardiac cells from apoptosis via induction of endogenous antioxidant enzymes. J. Agric. Food Chem. 55 (2007) 1695-1701
7. Edwards J.E. Invasive candida infections - evolution of a fungal pathogen. N. Engl. J. Med. 324 (1991) 1060-1072
8. Edwards J.E., Bodey G.P., Boeden R.A., Buchner T., DePauw B.E., et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin. Infect. Dis. 25 (1997) 43-59
9. Fleury F.J. Adult vaginitis. Clin. Microbiol. Rev. 9 (1981) 345-348
10. Fisher-Hoch S.P., and Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin. Infect. Dis. 21 (1995) 897-904
11. Fonos V., and Cataldi L. Amphotericin B-induced nephrotoxicity: a review. J. Chemother. 12 (2000) 463-470
12. Gallis H.A., Drew R.H., and Pickard W.W. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12 (1990) 308-329
13. Guendez R., Kallithraka S., Makris D.P., and Kefalas P. An analytical survey of the polyphenols of seeds of varieties of grape (Vitis vinifera) cultivated in Greece: implications for exploitation as a source of value-added phytochemicals. Phytochem. Anal. 16 (2005) 17-23
14. Han Y. Grape seed extract protects mice against disseminated candidiasis. Nat. Prod. Sci. 9 (2003) 60-63
15. Han Y., and Cutler J.E. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63 (1995) 2714-2719
16. Han Y., and Lee J.H. Berberine synergy with amphotericin B against disseminated candidiasis in mice. Biol. Pharm. Bull. 28 (2005) 541-544
17. Han Y., Riesselman M.H., and Cutler J.E. Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody. Infect. Immun. 68 (2000) 1649-1654
18. Hartsel S.C., and Weiland T.R. Amphotericin B binds to amyloid fibrils and delays their formation: a therapeutic mechanism?. Biochemistry 42 (2003) 6228-6233
19. Horowitz B.J. Mycotic vulvovaginitis: a broad overview. Am. J. Obset. Gynecol. 165 (1991) 1188-1192
20. Jayaprakasha G.K., Selvi T., and Shkaria K.K. Antibacterial and antioxidant activities of grape (Vitis vinifera) seed extracts. Food Res. Int. 36 (2001) 117-122
21. Koga T., Moro K., Nakamori K., Yamakoshi J., Hosoyama H., Kataoka S., and Ariga T. Increase of antioxidative potential of rat plasma by oral administration of proanthocyanidin-rich extract from grape seeds. J. Agric. Food Chem. 47 (1999) 1892
22. Lewis R.E., Lund B.C., Klepser M.E., Ernst E.J., and Pfaller M.A. Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model. Antimicrob. Agents Chemother. 42 (1998) 1382-1386
23. MacNeill C., Weisz J., and Carey J.C. Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance. J. Reprod. Med. 48 (2003) 63-68
24. Maeta K., Nomura W., Takatsume Y., Izuwa S., and Inoue Y. Appl. Environ. Microbiol. 73 (2007) 572-580
25. Marodi L., Kaposzta R., Campbell D.E., Polin R.A., Csongor J., and Johnston Jr. R.B. Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants. J. Immunol. 153 (1994) 5643-5649
26. Masia Canuto M., and Gutierrez Rodero F. Antifungal drug resistance to azoles and polyenes. Lancet Infect. Dis. 2 (2002) 550-563
27. Matsuoka S., and Murata M. Cholesterol markedly reduces ion permeability induced by membrane-bound amphotericin B. Biochim. Biophys. Acta 1564 (2002) 429-434
28. Mayer J., Doubek M., Doubek J., Horky D., Scheer P., and Stepanek M. Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study. J. Infect. Dis. 186 (2002) 379-388
29. Nair N., Mahajan S., Chawda R., Kandaswami C., Shanahan T.C., and Schwartz S.A. Grape seed extract activates Th1 cells in vitro. Clin. Diagn. Lab. Immunol. 9 (2002) 470-476
30. Okubo S., Toda M., Hara Y., and Shimamura T. Nippon Saikingaku Zasshi 46 (1991) 509-514
31. Sanglard D., Ischer F., Parkinso T., Falconer D., and Bille J. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob. Agents Chemother. 47 (2003) 2404-2412
32. Schaberg D.R., Culver D.H., and Gaynes R.P. Major trends in the microbial etiology of nosocomial infection. Am. J. Med. 16 (1991) 72S-75S
33. Sugar A.M., Hitchcock C.A., Troke P.F., and Picard M. Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B. Antimicrob. Agents Chemother. 39 (1995) 598-601
34. Vazquez J.A., Arganoza M.T., Vaishampayan J.K., and Akins R.A. In vitro interaction between amphotericin B and azoles in Candida albicans. Antimicrob. Agents Chemother. 40 (1996) 2511-2516
35. Williamson E.M. Synergy and other interactions in phytomedicines. Phytomedicine 8 (2001) 401-409